GB1254057A - Improvements in or relating to therapeutical composition containing vincamine - Google Patents

Improvements in or relating to therapeutical composition containing vincamine

Info

Publication number
GB1254057A
GB1254057A GB21084/69A GB2108469A GB1254057A GB 1254057 A GB1254057 A GB 1254057A GB 21084/69 A GB21084/69 A GB 21084/69A GB 2108469 A GB2108469 A GB 2108469A GB 1254057 A GB1254057 A GB 1254057A
Authority
GB
United Kingdom
Prior art keywords
mixture
relating
composition containing
vincamine
glycocoll
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB21084/69A
Other languages
English (en)
Inventor
Louisette Olivier
Odile Albert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB21084/69A priority Critical patent/GB1254057A/en
Priority to BE732141A priority patent/BE732141A/xx
Publication of GB1254057A publication Critical patent/GB1254057A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GB21084/69A 1969-04-24 1969-04-24 Improvements in or relating to therapeutical composition containing vincamine Expired GB1254057A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB21084/69A GB1254057A (en) 1969-04-24 1969-04-24 Improvements in or relating to therapeutical composition containing vincamine
BE732141A BE732141A (ja) 1969-04-24 1969-04-25

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21084/69A GB1254057A (en) 1969-04-24 1969-04-24 Improvements in or relating to therapeutical composition containing vincamine

Publications (1)

Publication Number Publication Date
GB1254057A true GB1254057A (en) 1971-11-17

Family

ID=10156932

Family Applications (1)

Application Number Title Priority Date Filing Date
GB21084/69A Expired GB1254057A (en) 1969-04-24 1969-04-24 Improvements in or relating to therapeutical composition containing vincamine

Country Status (2)

Country Link
BE (1) BE732141A (ja)
GB (1) GB1254057A (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0243278A1 (fr) * 1986-04-25 1987-10-28 Pierre Fabre Medicament Solution aqueuse stable de sulfate de vincristine
EP0298192A1 (en) * 1987-07-06 1989-01-11 Teva Pharmaceutical Industries Limited Stable, injectable solutions of vincristine salts
CN101721361B (zh) * 2009-12-08 2013-06-26 李荣立 长春胺注射剂及其制备工艺

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA902519B (en) * 1989-04-04 1991-12-24 Lilly Co Eli Pharmaceutical formulations

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0243278A1 (fr) * 1986-04-25 1987-10-28 Pierre Fabre Medicament Solution aqueuse stable de sulfate de vincristine
FR2597750A1 (fr) * 1986-04-25 1987-10-30 Pf Medicament Solution aqueuse stable de sulfate de vincristine
US4966903A (en) * 1986-04-25 1990-10-30 Pierre Fabre Medicament Stable aqueous solution of vincristine sulfate
EP0298192A1 (en) * 1987-07-06 1989-01-11 Teva Pharmaceutical Industries Limited Stable, injectable solutions of vincristine salts
CN101721361B (zh) * 2009-12-08 2013-06-26 李荣立 长春胺注射剂及其制备工艺

Also Published As

Publication number Publication date
BE732141A (ja) 1969-10-01

Similar Documents

Publication Publication Date Title
CA989308A (en) Unjectable amino acid composition commensurate to the anabolic need of the body and method of using same
GB1374823A (en) Triazolylbenzophenones
GB1330878A (en) Ketamine resolution
GB1390772A (en) Oral narcotic composition
IL29735A (en) Process for the preparation of pyrazinoylguanidines and new pyrazinoic acid azides
GB1254057A (en) Improvements in or relating to therapeutical composition containing vincamine
AU4368972A (en) Improvements relating to in vitro determination of active substance in a body
AU449293B2 (en) New adenosine-5'carboxylic acid derivatives andthe preparation thereof
GB1210968A (en) Improvements in or relating to the treatment of gastric ailments
IL40123A (en) 2-amino-4-phenyl-2-imidazolines and pharmaceutically acceptable acid addition salts thereof and methods for their preparation
PH9563A (en) Protected decapeptide derivatives of gonadotropin releasing hormone
GB1322112A (en) 3,4,5-trimethoxybenzoic acid derivatives and their uses
GB1460325A (en) Pharmaceutical composition intended for relieving pain and producing analgesia
ZA722837B (en) Procedure for enzymatic scission of "natural penicillins and for enzymatic syntnesis of"semisynthetic"penicillins by means of an insoluble acilase and for enzymatic sciccion having similar therapeutic properties
IL34935A (en) Esters of n-(3-trifluoromethyl-phenyl)-anthranilic acid and process for preparation
GB1354263A (en) Therapeutic composition
GB1202885A (en) Pharmaceutical compositions comprising alkaloids
CA922691A (en) Process for the preparation of 21-deoxy-21-n-/n' -methylpiperazinyl/ -prednisolone and salts
FR2108993A1 (en) Vincamine alkaloid fraction - with sedative and vasoregulating effect
GB1330993A (en) Mixture of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinsons disease
GB1191554A (en) New Analgesic Composition.
GB1254893A (en) Therapeutic composition
GB1254125A (en) Pharmaceutical composition suitable for the treatment of certain vascular diseases
GB1127748A (en) Pharmaceutical compositions for use in the treatment of disturbances due to luteinic deficiency
CA888650A (en) Method of administering amino acids to convalescing livestock